Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank57
Studio
Year-over-Year Change

Return on invested capital

Latest
-16.64%
↑ 45% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-30.14%
Historical baseline
PeriodValueYoY Change
2025-16.64%+59.0%
2024-40.60%+35.1%
2023-62.53%-112.5%
2022-29.42%-308.3%
2021-7.20%+55.4%
2020-16.17%-116.6%
2019-7.47%+87.8%
2018-61.09%-